BCLI – Brainstorm Cell Therapeutics, Inc.
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Float Short %
2.06
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
1.8
EPS Last/This Y
EPS This/Next Y
0.51
Price
1.76
Target Price
10
Analyst Recom
1
Performance Q
41.8
Relative Volume
0.15
Beta
0.72
Ticker: BCLI
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-01-23 | BCLI | 2.14 | N/A | N/A | 0 |
| 2025-01-24 | BCLI | 2.18 | N/A | N/A | 0 |
| 2025-01-27 | BCLI | 2.03 | N/A | N/A | 0 |
| 2025-01-28 | BCLI | 1.99 | N/A | N/A | 0 |
| 2025-01-29 | BCLI | 2.03 | N/A | N/A | 0 |
| 2025-01-30 | BCLI | 1.91 | N/A | N/A | 0 |
| 2025-01-31 | BCLI | 1.83 | N/A | N/A | 0 |
| 2025-02-03 | BCLI | 1.835 | N/A | N/A | 0 |
| 2025-02-04 | BCLI | 1.84 | N/A | N/A | 0 |
| 2025-02-05 | BCLI | 1.873 | N/A | N/A | 0 |
| 2025-02-06 | BCLI | 1.83 | N/A | N/A | 0 |
| 2025-02-07 | BCLI | 1.713 | N/A | N/A | 0 |
| 2025-02-10 | BCLI | 1.71 | N/A | N/A | 0 |
| 2025-02-11 | BCLI | 1.747 | 0.02 | 0.00 | 851 |
| 2025-02-12 | BCLI | 1.77 | 0.02 | 0.00 | 851 |
| 2025-02-13 | BCLI | 1.79 | 0.02 | 0.00 | 851 |
| 2025-02-14 | BCLI | 1.813 | 0.02 | 0.00 | 851 |
| 2025-02-18 | BCLI | 1.84 | 0.02 | 0.00 | 851 |
| 2025-02-19 | BCLI | 1.81 | N/A | N/A | 0 |
| 2025-02-20 | BCLI | 1.81 | N/A | N/A | 0 |
| 2025-02-21 | BCLI | 1.73 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-01-23 | BCLI | 2.16 | 82.0 | - | -2.10 |
| 2025-01-24 | BCLI | 2.20 | 82.0 | - | -2.10 |
| 2025-01-27 | BCLI | 2.03 | 82.0 | - | -2.10 |
| 2025-01-28 | BCLI | 2.00 | 82.0 | - | -2.10 |
| 2025-01-29 | BCLI | 2.02 | 82.0 | - | -2.10 |
| 2025-01-30 | BCLI | 1.91 | 82.0 | - | -2.10 |
| 2025-01-31 | BCLI | 1.83 | 82.0 | - | -2.10 |
| 2025-02-03 | BCLI | 1.84 | 82.0 | - | -2.10 |
| 2025-02-04 | BCLI | 1.84 | 82.0 | - | -2.10 |
| 2025-02-05 | BCLI | 1.88 | 82.0 | - | -2.10 |
| 2025-02-06 | BCLI | 1.81 | 82.0 | - | -2.10 |
| 2025-02-07 | BCLI | 1.71 | 82.0 | - | -2.10 |
| 2025-02-10 | BCLI | 1.72 | 82.0 | - | -2.10 |
| 2025-02-11 | BCLI | 1.74 | 82.0 | - | -2.10 |
| 2025-02-12 | BCLI | 1.81 | 82.0 | - | -2.10 |
| 2025-02-13 | BCLI | 1.79 | 82.0 | - | -2.10 |
| 2025-02-14 | BCLI | 1.86 | 82.0 | - | -2.10 |
| 2025-02-18 | BCLI | 1.86 | 82.0 | - | -2.10 |
| 2025-02-19 | BCLI | 1.80 | 82.0 | - | -2.10 |
| 2025-02-20 | BCLI | 1.77 | 82.0 | - | -2.10 |
| 2025-02-21 | BCLI | 1.76 | 82.0 | - | -2.10 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-01-23 | BCLI | -2.98 | -2.70 | 2.11 |
| 2025-01-24 | BCLI | -2.98 | -2.70 | 2.11 |
| 2025-01-27 | BCLI | 1.91 | 58.98 | 2.11 |
| 2025-01-28 | BCLI | 1.91 | 58.98 | 3.90 |
| 2025-01-29 | BCLI | 1.91 | 58.98 | 3.90 |
| 2025-01-30 | BCLI | 1.91 | 58.98 | 3.90 |
| 2025-01-31 | BCLI | 1.91 | 58.98 | 3.90 |
| 2025-02-03 | BCLI | 1.91 | 53.49 | 3.90 |
| 2025-02-04 | BCLI | 1.91 | 53.49 | 3.90 |
| 2025-02-05 | BCLI | 1.91 | 53.49 | 3.90 |
| 2025-02-06 | BCLI | 1.91 | 53.49 | 3.90 |
| 2025-02-07 | BCLI | 1.91 | 53.49 | 3.90 |
| 2025-02-10 | BCLI | 1.91 | 52.98 | 3.90 |
| 2025-02-11 | BCLI | 1.91 | 52.98 | 3.90 |
| 2025-02-12 | BCLI | 1.91 | 52.98 | 2.06 |
| 2025-02-13 | BCLI | 1.91 | 52.98 | 2.06 |
| 2025-02-14 | BCLI | 1.91 | 52.98 | 2.06 |
| 2025-02-18 | BCLI | 1.91 | 60.70 | 2.06 |
| 2025-02-19 | BCLI | 1.91 | 60.70 | 2.06 |
| 2025-02-20 | BCLI | 1.91 | 60.70 | 2.06 |
| 2025-02-21 | BCLI | 1.91 | 60.70 | 2.06 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.8
Avg. EPS Est. Current Quarter
-0.27
Avg. EPS Est. Next Quarter
Insider Transactions
1.91
Institutional Transactions
60.7
Beta
0.72
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
35
Growth Score
21
Sentiment Score
74
Actual DrawDown %
99.4
Max Drawdown 5-Year %
-99.6
Target Price
10
P/E
Forward P/E
PEG
P/S
P/B
P/Free Cash Flow
EPS
-3.49
Average EPS Est. Cur. Y
-2.1
EPS Next Y. (Est.)
-1.59
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.15
Return on Equity vs Sector %
215.7
Return on Equity vs Industry %
231.3
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.21
EBIT Estimation
stock quote shares BCLI – Brainstorm Cell Therapeutics, Inc. Stock Price stock today
news today BCLI – Brainstorm Cell Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BCLI – Brainstorm Cell Therapeutics, Inc. yahoo finance google finance
stock history BCLI – Brainstorm Cell Therapeutics, Inc. invest stock market
stock prices BCLI premarket after hours
ticker BCLI fair value insiders trading